Farallon Capital Management LLC Better Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.69 - $1.46 $254,211 - $537,897	-368,423 Reduced 52.7%	330,619 $357,000
Q1 2023 May 15, 2023	SELL	$0.64 - $1.45 $73,288 - $166,045	-114,514 Reduced 14.08%	699,042 $489,000
Q4 2022 Feb 14, 2023	SELL	$1.1 - $1.74 $205,088 - $324,412	-186,444 Reduced 18.64%	813,556 $894,000
Q2 2022 Aug 15, 2022	SELL	$0.91 - $2.34 $134,134 - $344,916	-147,400 Reduced 12.85%	1,000,000 $1.56 Million
Q1 2022 May 16, 2022	SELL	$1.98 - $5.01 $401,148 - $1.02 Million	-202,600 Reduced 15.01%	1,147,400 $2.27 Million
Q4 2021 Feb 14, 2022	BUY	$4.58 - $17.14 $6.18 Million - $23.1 Million	1,350,000 New	1,350,000 $6.28 Million

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.